Cargando…
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
BACKGROUND: The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5 mg·L(−1) cut-off) followed by confirmatory testing if screen positive. We conducted an indiv...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245131/ https://www.ncbi.nlm.nih.gov/pubmed/37286216 http://dx.doi.org/10.1183/16000617.0021-2023 |
_version_ | 1785054796848300032 |
---|---|
author | Dhana, Ashar Gupta, Rishi K. Hamada, Yohhei Kengne, Andre P. Kerkhoff, Andrew D. Yoon, Christina Cattamanchi, Adithya Reeve, Byron W.P. Theron, Grant Ndlangalavu, Gcobisa Wood, Robin Drain, Paul K. Calderwood, Claire J. Noursadeghi, Mahdad Boyles, Tom Meintjes, Graeme Maartens, Gary Barr, David A. |
author_facet | Dhana, Ashar Gupta, Rishi K. Hamada, Yohhei Kengne, Andre P. Kerkhoff, Andrew D. Yoon, Christina Cattamanchi, Adithya Reeve, Byron W.P. Theron, Grant Ndlangalavu, Gcobisa Wood, Robin Drain, Paul K. Calderwood, Claire J. Noursadeghi, Mahdad Boyles, Tom Meintjes, Graeme Maartens, Gary Barr, David A. |
author_sort | Dhana, Ashar |
collection | PubMed |
description | BACKGROUND: The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5 mg·L(−1) cut-off) followed by confirmatory testing if screen positive. We conducted an individual participant data meta-analysis to determine the performance of WHO-recommended screening tools and two newly developed clinical prediction models (CPMs). METHODS: Following a systematic review, we identified studies that recruited adult outpatient PLHIV irrespective of tuberculosis signs and symptoms or with a positive W4SS, evaluated CRP and collected sputum for culture. We used logistic regression to develop an extended CPM (which included CRP and other predictors) and a CRP-only CPM. We used internal–external cross-validation to evaluate performance. RESULTS: We pooled data from eight cohorts (n=4315 participants). The extended CPM had excellent discrimination (C-statistic 0.81); the CRP-only CPM had similar discrimination. The C-statistics for WHO-recommended tools were lower. Both CPMs had equivalent or higher net benefit compared with the WHO-recommended tools. Compared with both CPMs, CRP (5 mg·L(−1) cut-off) had equivalent net benefit across a clinically useful range of threshold probabilities, while the W4SS had a lower net benefit. The W4SS would capture 91% of tuberculosis cases and require confirmatory testing for 78% of participants. CRP (5 mg·L(−1) cut-off), the extended CPM (4.2% threshold) and the CRP-only CPM (3.6% threshold) would capture similar percentages of cases but reduce confirmatory tests required by 24, 27 and 36%, respectively. CONCLUSIONS: CRP sets the standard for tuberculosis screening among outpatient PLHIV. The choice between using CRP at 5 mg·L(−1) cut-off or in a CPM depends on available resources. |
format | Online Article Text |
id | pubmed-10245131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-102451312023-06-08 Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis Dhana, Ashar Gupta, Rishi K. Hamada, Yohhei Kengne, Andre P. Kerkhoff, Andrew D. Yoon, Christina Cattamanchi, Adithya Reeve, Byron W.P. Theron, Grant Ndlangalavu, Gcobisa Wood, Robin Drain, Paul K. Calderwood, Claire J. Noursadeghi, Mahdad Boyles, Tom Meintjes, Graeme Maartens, Gary Barr, David A. Eur Respir Rev Reviews BACKGROUND: The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5 mg·L(−1) cut-off) followed by confirmatory testing if screen positive. We conducted an individual participant data meta-analysis to determine the performance of WHO-recommended screening tools and two newly developed clinical prediction models (CPMs). METHODS: Following a systematic review, we identified studies that recruited adult outpatient PLHIV irrespective of tuberculosis signs and symptoms or with a positive W4SS, evaluated CRP and collected sputum for culture. We used logistic regression to develop an extended CPM (which included CRP and other predictors) and a CRP-only CPM. We used internal–external cross-validation to evaluate performance. RESULTS: We pooled data from eight cohorts (n=4315 participants). The extended CPM had excellent discrimination (C-statistic 0.81); the CRP-only CPM had similar discrimination. The C-statistics for WHO-recommended tools were lower. Both CPMs had equivalent or higher net benefit compared with the WHO-recommended tools. Compared with both CPMs, CRP (5 mg·L(−1) cut-off) had equivalent net benefit across a clinically useful range of threshold probabilities, while the W4SS had a lower net benefit. The W4SS would capture 91% of tuberculosis cases and require confirmatory testing for 78% of participants. CRP (5 mg·L(−1) cut-off), the extended CPM (4.2% threshold) and the CRP-only CPM (3.6% threshold) would capture similar percentages of cases but reduce confirmatory tests required by 24, 27 and 36%, respectively. CONCLUSIONS: CRP sets the standard for tuberculosis screening among outpatient PLHIV. The choice between using CRP at 5 mg·L(−1) cut-off or in a CPM depends on available resources. European Respiratory Society 2023-06-07 /pmc/articles/PMC10245131/ /pubmed/37286216 http://dx.doi.org/10.1183/16000617.0021-2023 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Reviews Dhana, Ashar Gupta, Rishi K. Hamada, Yohhei Kengne, Andre P. Kerkhoff, Andrew D. Yoon, Christina Cattamanchi, Adithya Reeve, Byron W.P. Theron, Grant Ndlangalavu, Gcobisa Wood, Robin Drain, Paul K. Calderwood, Claire J. Noursadeghi, Mahdad Boyles, Tom Meintjes, Graeme Maartens, Gary Barr, David A. Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis |
title | Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis |
title_full | Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis |
title_fullStr | Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis |
title_full_unstemmed | Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis |
title_short | Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis |
title_sort | clinical utility of who-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with hiv: an individual participant data meta-analysis |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245131/ https://www.ncbi.nlm.nih.gov/pubmed/37286216 http://dx.doi.org/10.1183/16000617.0021-2023 |
work_keys_str_mv | AT dhanaashar clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT guptarishik clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT hamadayohhei clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT kengneandrep clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT kerkhoffandrewd clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT yoonchristina clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT cattamanchiadithya clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT reevebyronwp clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT therongrant clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT ndlangalavugcobisa clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT woodrobin clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT drainpaulk clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT calderwoodclairej clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT noursadeghimahdad clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT boylestom clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT meintjesgraeme clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT maartensgary clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis AT barrdavida clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis |